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Abstract
In this paper, dynamical systems theory and bifurcation theory are applied to investi-
gate the rich dynamical behaviours observed in three simple disease models. The 2- and
3-dimensional models we investigate have arisen in previous investigations of epidemiol-
ogy, in-host disease, and autoimmunity. These closely related models display interesting
dynamical behaviors including bistability, recurrence, and regular oscillations, each of
which has possible clinical or public health implications. In this contribution we elucidate
the key role of backward bifurcation in the parameter regimes leading to the behaviors
of interest. We demonstrate that backward bifurcation facilitates the appearance of Hopf
bifurcations, and the varied dynamical behaviors are then determined by the properties of
the Hopf bifurcation(s), including their location and direction. A Maple program devel-
oped earlier is implemented to determine the stability of limit cycles bifurcating from the
Hopf bifurcation. Numerical simulations are presented to illustrate phenomena of interest
such as bistability, recurrence and oscillation. We also discuss the physical motivations
for the models and the clinical implications of the resulting dynamics.
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3 Introduction
In the mathematical modelling of epidemic diseases, the fate of the disease can be predicted
through the uninfected and infected equilibria and their stability. The basic reproduction num-
ber, R0, represents the average number of new infectives introduced into an otherwise disease-
free system by a single infective, and is usually chosen as the bifurcation parameter. If the
model involves a forward bifurcation, the uninfected equilibrium is in general globally asymp-
totically stable [28], characterized by R0 < 1, and infection fails to invade in this parameter
regime. The threshold R0 = 1 defines a bifurcation (or critical) point, and when R0 > 1, a
stable infected equilibrium emerges. This simple exchange of stability implies that complex
dynamics will not typically occur in forward bifurcation.
In contrast, backward bifurcation describes a scenario in which a turning point of the in-
fected equilibrium exists in a region where all state variables are positive, and R0 < 1. This
induces multiple infected equilibria, disrupting the global stability of the uninfected equilib-
rium. Multiple stable states (e.g., bistability) may likewise appear in [15, 4, 2], and Yu et al.
(submitted for publication). Instead of converging globally to the uninfected equilibrium when
R0 < 1, the solution may approach an infected equilibrium, depending on initial conditions.
In practice, the phenomenon of backward bifurcation gives rise to new challenges in dis-
ease control, since reducing R0 such that R0 < 1 is not sufficient to eliminate the disease [22, 5].
Instead, R0 needs to be reduced past the critical value given by the turning point [22], since
the result in Yu et al. (submitted for publication) shows that the uninfected equilibrium in
backward bifurcation is globally stable if R0 is smaller than the turning point. Furthermore, an
infective outbreak or catastrophe may occur if R0 increases and crosses unity, while the upper
branch of the infected equilibrium remains stable [15, 21, 47, 48]. In addition, oscillation or
even recurrent phenomena may occur if uninfected and infected equilibria coexist in a param-
eter range, and both are unstable [47, 48]. [22] predicted oscillations arising from backward
bifurcation, and [5] pointed out that the unstable infected equilibrium “commonly arises from
Hopf bifurcation”, but did not demonstrate oscillations.
Several mechanisms leading to backward bifurcation have been proposed, such as partially
effective vaccination programs [5, 2], educational influence on infectives’ behavior [22], the
interaction among multi-group models [9, 10, 25] and multiple stages of infection [40]. In
this study, we will investigate the emergence of backward bifurcation in three simple disease
models which have arisen in the study of epidemiology, in-host disease and autoimmunity. In
each case, we find that backward bifurcation facilitates the emergence of Hopf bifurcation(s),
and Hopf bifurcation in turn underlies a range of complex and clinically relevant dynamical
behaviors.
A central theme in our investigation is the role of the incidence rate in the epidemiological
and in-host disease models. The incidence rate describes the speed at which an infection
spreads; it denotes the rate at which susceptibles become infectives. Under the assumptions
of mass action, incidence is written as the product of the infection force and the number of
susceptibles. For example, if S and I denote the susceptible and infective population size
respectively, a bilinear incidence rate, f (S, I) = βSI (where β is a positive constant), is linear
in each of the state variables: S and I.
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The possibility of saturation effects [8, 7] has motivated the modification of the incidence
rate from bilinear to nonlinear. Saturation occurs when the number of susceptible contacts
per infective drops off as the proportion of infectives increases. A nonlinear incidence rate,
therefore, typically increases sublinearly with respect to the growth of the infective population,
and may finally reach an upper bound. The development of nonlinear incidence was first
investigated in the form β IpSq, where β , p, and q are positive constants [32, 31, 23, 24, 13, 29].
Other forms of nonlinear incidence have also been analysed, such as kIpS/(1+αIl) [32], and
kS ln(1+ vP/k) [6].
Since the nonlinear incidence functions described above were often developed to incor-
porate saturation effects, these functions are typically concave at realistic parameter values.
[28] used this feature to derive general results for disease models with concave incidence.
They proved that standard epidemiological models with concave incidence functions will have
globally asymptotically stable uninfected and infected equilibria for R0 < 1 and R0 > 1, re-
spectively.
More specifically, denoting the incidence rate function as f (S, I, N), where N is the popu-
lation size, the classical SIRS model considered in [28] takes the form
dS
dt
= µN− f (S, I, N)−µS+αR, dI
dt
= f (S, I, N)− (δ +µ)I, dR
dt
= δ I−αR−µR, (1)
where µ , δ , and α represent the birth/death rate, the recovery rate and the loss of immunity
rate, respectively. When α = 0, system (1) becomes an SIR model. Assuming that the total
population size is constant, that is, N = S+ I +R, the above system can be reduced to a 2-
dimensional model:
dS
dt
= (α+µ)N− f (S, I, N)−αI− (α+µ)S, dI
dt
= f (S, I, N)− (δ +µ)I. (2)
Moreover, it is assumed in [28] that the function f (S, I, N), denoting the incidence rate, satis-
fies the following three conditions:
f (S, 0, N) = f (0, I, N) = 0, (3a)
∂ f (S, I, N)
∂ I
> 0,
∂ f (S, I, N)
∂S
> 0, ∀ S, I > 0 (3b)
∂ 2 f (S, I, N)
∂ I2
≤ 0, ∀ S, I > 0. (3c)
The first two conditions (3a) and (3b) are necessary to ensure that the model is biologically
meaningful. The third condition (3c) implies that the incidence rate f (S, I, N), is concave
with respect to the number of infectives. It is also assumed that ∂ f (S, I,N)∂ I evaluated at the
uninfected equilibrium is proportional to the basic reproduction number R0 [42], and thus
should be a positive finite number [28]. Korobeinikov and Maini first considered I˙ = 0, or
f (S, I, N)− (δ + µ)I = 0, and showed that forward bifurcation occurs in model (2) with
a concave incidence function. They further proved that the uninfected equilibrium Q0 =
(S0, I0) = (N, 0) and the infected equilibrium Q¯ = (S¯, I¯) are globally asymptotically stable,
when R0 = 1δ+µ
∂ f (S0, I0,N)
∂ I < 1 and R0 > 1, respectively.
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In the sections to follow, for an incidence rate function f (S, I), satisfying (3a) and (3b), we
define f (S, I) as concave, if it satisfies (3c); as convex, if ∂
2 f (S, I)
∂ I2 > 0, ∀ I > 0; and as convex-
concave, if there exist 0 < I1 < I2 ≤ +∞, such that ∂ f (S, I)∂ I > 0, ∀ I ∈ (0, I2), and ∂
2 f (S, I)
∂ I2 > 0,
∀ I ∈ (0, I1), ∂
2 f (S, I)
∂ I2 = 0, for I = I1,
∂ 2 f (S, I)
∂ I2 < 0, ∀ I ∈ (I1, I2).
Several models closely related to (2) have been previously studied. For example, by adding
a saturating treatment term to model (2) with a concave incidence rate, [49] showed that this
model may yield backward bifurcation and Hopf bifurcation. With an even more sophisticated
nonlinear incidence rate function: kIpS/(1+αIl), where p= l = 2, [38] proved that a reduced
2-dimensional SIRS model could exhibit backward bifurcation, Hopf bifurcation, and even
Bogdanov-Takens bifurcation and homoclinic bifurcation. Although the choice of p = l =
2 was not motivated by a specific physical process, this important result demonstrates that
a nonlinear incidence rate can induce backward bifurcation, and further generate complex
dynamics in a simple disease model.
One of the focal points of our study will be a convex incidence function which arose in a
4-dimensional HIV antioxidant therapy model [43]. In this model, the infectivity of infected
cells was proposed to be an increasing function of the density of reactive oxygen species,
which themselves increase as the infection progresses. In [43], meaningful parameter values
were carefully chosen by data fitting to both experimental and clinical results. In this parameter
regime, the model was observed to capture the phenomenon of viral blips, that is, long periods
of undetectable viral load punctuated by brief episodes of high viral load. Viral blips have been
observed clinically in HIV patients under highly active antiretroviral therapy [11, 14, 35, 34],
and have received much attention in the research literature, both by experimentalists [17, 18,
20] and mathematicians [16, 27, 12, 37, 36]. Nonetheless, the mechanisms underlying this
phenomenon are still not thoroughly understood [20, 36].
We recently re-examined the model developed in [43], with the aim of providing new
insight into the mechanism of HIV viral blips [47, 48]. Focusing on the dynamics of the slow
manifold of this model, we reduced the dimension of the 4-dimensional model by using quasi-
steady state assumptions. After a further generalization and parameter rescaling process, a
2-dimensional in-host HIV model [47, 48] was obtained, given by
dX
dτ
= 1−DX− (B+ AY
Y +C
)XY,
dY
dτ
= (B+
AY
Y +C
)XY −Y, (4)
where X and Y denote the concentrations of the uninfected and infected cells respectively. The
constant influx rate and the death rate of Y have been scaled to 1. The death rate of X is D. The
2-dimensional infection model above (4), reduced from the 4-dimensional HIV model [43],
preserves the viral blips observed in the HIV model.
Importantly, system (4) is equivalent to the SIR model (2), except that the incidence func-
tion is convex, as we will show in section 4.2. This equivalence can be demonstrated if we set
S = e1x, I = e2y, and t = e3τ with e1 = e2 = µNδ+µ and e3 =
1
δ+µ . In this case, system (2) is
rescaled to
dx
dτ
= 1− µ
δ +µ
x− 1
µN
f (x, y),
dy
dτ
=
1
µN
f (x, y)− y,
which takes the same form as system (4). Therefore, although system (2) arises in epidemi-
ology and system (4) was derived as an in-host model, they are mathematically equivalent in
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this sense. We will refer to both systems (2) and (4) as infection models.
In previous work [47, 48], we analyze the recurrent behavior which emerges in system (4)
in some detail. Recurrence is a particular form of oscillatory behavior characterized by long
periods of time close to the uninfected equilibrium, punctuated by brief episodes of high in-
fection [45]. Thus HIV viral blips are an example of recurrent behavior, but recurrence is a
more general feature of many diseases [45, 48]. We have demonstrated that the increasing and
saturating infectivity function of system (4) is critical to the emergence of recurrent behaviour.
This form of an infectivity function corresponds to a convex incidence rate function in the as-
sociated 2-dimensional infection model (4), and can likewise induce recurrence in this model.
Convex incidence has been previously suggested to model ‘cooperation effects’ in epidemiol-
ogy [28], or cooperative phenomena in reactions between enzyme and substrate, as proposed
by [33].
The rest of this paper is organized as follows. In Section 2, we study two 2-dimensional
infection models, both closely related to system (2). We show that system (2) with either
(a) a concave incidence rate and saturating treatment term or (b) a convex incidence rate as
shown in system (4), can exhibit backward bifurcation; we then identify the necessary terms
in the system equations which cause this phenomenon. In Section 3, we demonstrate that
in both models, backward bifurcation increases the likelihood of a Hopf bifurcation on the
upper branch of the infected equilibrium. Studying system (4) in greater detail, we illustrate
how the location of the Hopf bifurcations and their directions (supercritical or subcritical),
determine the possible dynamical behaviors, concluding that backward bifurcation facilitates
Hopf bifurcation(s), which then underly the rich behaviours observed in these models. In
Section 4, we explore backward bifurcation further, presenting an autoimmune disease model
which exhibits negative backward bifurcation, that is, a bifurcation for which the turning point
when R0 < 1 is located in a region where one or more state variables is negative. Although
this bifurcation introduces two branches of the infected equilibrium, we demonstrate that, in
the biologically feasible area, only forward bifurcation exists in this model. We then present a
modification to this autoimmune model, motivated by the recent discovery of a new cell type,
which generates a negative backward bifurcation and Hopf bifurcation, and allows recurrent
behavior to emerge. A conclusion is drawn in Section 5.
4 Backward bifurcation
In this section, we study backward bifurcation in two 2-dimensional infection models. In
particular, we explore the essential terms and parameter relations which are needed to generate
backward bifurcation. Furthermore, we examine the convex incidence rate, and reveal its
underlying role in determining the emergence of backward bifurcation.
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4.1 Backward bifurcation in the infection model with concave incidence
First, we consider the SIR model with concave incidence, described by the following equa-
tions [49]:
dS
dt
= Λ− βSI
1+ kI
−dS, dI
dt
=
βSI
1+ kI
− (d+ γ+ ε)I, dR
dt
= γI−dR, (5)
where S, I and R denote the number of susceptible, infective, and recovered individuals, re-
spectively; Λ is the constant recruitment rate of susceptibles; d, γ , and ε represent the rates of
natural death, recovery, and the disease-induced mortality, respectively. Note that the function
βSI
1+kI is an incidence rate of the form
kIlS
1+αIh [32], when l = h = 1. Here, β is the infection
rate, and k measures the inhibition effect. Since the variable R is not involved in the first two
equations, system (5) can be reduced to a 2-dimensional model as
dS
dt
= Λ− βSI
1+ kI
−dS, dI
dt
=
βSI
1+ kI
− (d+ γ+ ε)I. (6)
In [49], an additional assumption regarding limited medical treatment resources is introduced
to the above model, leading to a model with a saturating treatment term, given by
dS
dt
= f1(S, I) = Λ− βSI1+ kI −dS,
dI
dt
= f2(S, I) =
βSI
1+ kI
− (d+ γ+ ε)I− αI
ω+ I
, (7)
where the real, positive parameter α represents the maximal medical resources per unit time,
and the real, positive parameter ω is the half-saturation constant. For simplicity, let the func-
tions on the right-hand side of the equations in (7) be f1 and f2, respectively. Then, the
equilibrium solutions of system (7) are obtained by solving the following algebraic equa-
tions: f1(S, I) = 0 and f2(S, I) = 0, from which the disease-free equilibrium can be easily
obtained as E¯0 = (Λ/d, 0). For the infected equilibrium E¯ = (S¯, I¯), S¯ is solved from f1 = 0 as
S¯(I) =
Λ(1+ kI)
(dk+β )I+d
. Then, substituting S = S¯(I) into f2 = 0 yields a quadratic equation of
the form
F (I) =A I2+BI+C = 0, (8)
which in turn gives two roots: I¯1,2 = −B±
√
B2−4A C
2A , where, A = (d + γ + ε)(dk + β ),
B = [(dk+ β )ω + d](d + γ + ε) + (dk+ β )α − βΛ, C = [(d + γ + ε)ω +α]d − βΛω for
system (7). Since all parameters take positive values, we have A > 0. To get the two positive
roots essential for backward bifurcation, it is required that B < 0 and C > 0. Noticing that
β , Λ, ω > 0, we can see that the infection force, β , the constant influx of the susceptibles,
Λ, and the effect of medical treatment αIω+I are indispensible terms for backward bifurcation.
The number of positive infected equilibrium solutions changes from two to one when the
value of C passes from negative to positive, which gives a critical point at C = 0, that is,
[(d+ γ+ ε)ω+α]d = βΛω , which is equivalent to R0 = βΛ(d+γ+ε+α/ω)d = 1.
On the other hand, we may infer the emergence of backward bifurcation without solving
the equilibrium conditions. If we do not consider the medical treatment term αIω+I and remove
it from system (7), that leads to system (6), which is a typical example of an SIR model studied
by (2). By setting the incidence function as f3(S, I) =
βSI
1+kI , we have f3(0, I) = f3(S, 0) = 0;
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(a)
I
f3(S˜, I) =
β S˜I
1+ kI
g1(I) = (d+ γ+ ε)I
(b)
I
f4(S˜, I) =
β S˜I
1+ kI
− αI
ω+ I
g1(I) = (d+ γ+ ε)I
Figure 1: Graphs of the incidence function f3 in system (5), (6) and function f4 in system (7)
with respect to I, for which S˜= 50 has been used. The parameter values are chosen as β = 0.01,
k = 0.01, α = 6, ω = 7, d = 0.1, γ = 0.01, ε = 0.02, according to [49]. The solid lines denote
f3 in (a) and f4 in (b), while the dashed ray lines in both graphs represent g1(I) = (d+γ+ε)I.
(a) the incidence function f3(S, I) =
βSI
1+kI , showing one intersection point with g1; and (b) the
function f4(S, I) =
βSI
1+kI − αIω+I , showing two intersection points with g1.
∂ f3(S, I)
∂S =
β I
1+kI > 0 and
∂ f3(S, I)
∂ I =
βS
(1+kI)2 > 0 for all S, I > 0; and
∂ 2 f3(S, I)
∂ I2 = −2βkS(1+
kI)−3 < 0 for all S, I > 0. Therefore, the incidence function f3(S, I), satisfies the conditions
given in (3). In particular, the function is concave, and can only have one intersection point
with the line (d + γ + ε)I in the I-S plane, as shown in Figure 1(a). Thus, the uniqueness of
the positive infected equilibrium implies that backward bifurcation cannot occur in this case.
Moreover, according to the result in [28], the uninfected and infected equilibria are globally
asymptotically stable for R0 =
βΛ
d(d+γ+ε) < 1 and R0 > 1, respectively. No complex dynamical
behavior happens in system (6).
In contrast, when we introduce the loss of the infectives due to medical treatment, the
dynamics of system (7) differ greatly from system (6). In particular, backward bifurcation
emerges and complex dynamical behaviors may occur. To clarify this effect, we denote the
function induced by I˙ = 0 from (7) as f4(S, I) =
βSI
1+kI − αIω+I . Note that f4(S, I) is not an
incidence rate. But, if we fix S = S˜ > 0, there exist 0 < I1 < I2 < +∞, such that
∂ f4(S˜, I)
∂ I =
1
(1+kI)2(ω+I)2 [β S˜(ω+ I)
2−αω(1+kI)2]> 0, ∀ I ∈ (0, I2); and ∂
2 f4(S˜, I)
∂ I2 =−2kβ S˜(1+kI)−3+
2αω(ω + I)−3 > 0, ∀ I ∈ (0, I1), ∂
2 f4(S˜, I)
∂ I2 = 0, for I = I1,
∂ 2 f4(S˜, I)
∂ I2 < 0, ∀ I ∈ (I1, I2). Thus,
f4(S˜, I) actually has a convex-concave ‘S’ shape, and may have two positive intersection points
with the ray line, g1(I) = (d+γ+ε)I, in the first quadrant; see Figure 1(b). These intersections
contribute the two positive equilibrium solutions that are a necessary feature of backward
bifurcation.
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In summary we may conclude that the necessary terms which should be contained in sys-
tem (7) in order to have backward bifurcation are the constant influx Λ, the infection force β ,
and the saturating medical treatment αIω+I .
4.2 Backward bifurcation in the infection model with convex incidence
Now we consider the 2-dimensional infection model (4) which exhibits viral blips, studied
in [47, 48]. The motivation for this model was a series of clinical discoveries indicating
that viral infection can increase the density of a harmful chemical substance [19, 30, 39, 26],
thereby amplifying an associated biochemical reaction [41], and thus accelerating the infec-
tion rate [19]. This cooperative phenomenon in viral infection is expressed by an increasing,
saturating infectivity function: (B+ AYY+C). According to the principle of mass action, the in-
cidence function is then denoted as (B+ AYY+C)XY , which is a convex function with respect to
the infectives’ density Y .
To analyze the occurrence of possible backward bifurcation, we first examine the two equi-
librium solutions from the following equations:
f5(X , Y ) = 1−DX− (B+ AYY +C )XY = 0, f6(X , Y ) = (B+
AY
Y +C
)XY −Y = 0, (9)
where all parameters A, B, C and D are positive constants. It is easy to find the uninfected equi-
librium E¯0 = (X¯0, Y¯0) = ( 1D , 0), whose characteristic polynomial has two roots: λ1 =−D < 0,
and λ2 = BD−1, which gives R0 = BD . Consequently, E¯0 is stable (unstable) for R0 < 1(> 1). To
find the infected equilibrium solution, setting f6(X , Y ) = 0 yields X¯1(Y ) = Y+C(A+B)Y+BC , which
is then substituted into f5(X , Y ) = 0 to give the following quadratic equation:
F5(Y ) = (A+B)Y 2+(BC+D−A−B)Y +C(D−B) = 0. (10)
In order to have two real, positive roots, two conditions must be satisfied, that is, BC+D−
A−B < 0 and D−B > 0, or in compact form, 0 < D−B < A−BC. The condition D−B > 0
is equivalent to 0 < R0 = BD < 1, which is a necessary condition for backward bifurcation.
Moreover, the positive influx constant, having been scaled to 1, is a necessary term for the
positive equilibrium of Y . Therefore, the positive influx rate term and the increasing and
saturating infectivity function are necessary for backward bifurcation.
In the rest of the subsection, we further examine the incidence function,
f7(X , Y ) = (B+
AY
Y +C
)XY, (11)
without solving the equilibrium solutions. The incidence function f7 obviously satisfies the
condition (3a), as well as the condition (3b) since ∂∂X f7(X , Y ) = [B+AY (Y +C)
−1]Y > 0 and
∂
∂Y f7(X , Y ) = ACXY (Y +C)
−2 + [B+AY (Y +C)−1]X > 0 for all X , Y > 0. However, the
second partial derivative of f7(X , Y ) with respect to Y , ∂
2
∂Y 2 f7(X , Y ) = 2AC
2X(X +C)−3 >
0 for all X , Y > 0, showing that f7(X , Y ) is a convex function with respect to the variable
Y . Consequently, f7(X , Y ) can only have one intersection with g2(Y ) = Y , implying that
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Y(a)
f7(X˜ , Y ) in (11)
g2(Y ) = Y
0
0.14
0.15
Y
Y
(b)
f7(Y ) in (12)
g2(Y ) = Y
0.1
0 0.1
Y
Figure 2: Graphs of the incidence functions f7(X˜ ,Y ) and f7(Y ) for the parameter values A =
0.364, B = 0.03, C = 0.823, and D = 0.057. The incidence functions are denoted by the
solid lines, while the ray lines, determined by g2(Y ) = Y , are denoted by dotted lines: (a) the
incidence function f7(X˜ ,Y ), showing one intersection point with g2 with an inset, with a fixed
value X˜ = 12.54; and (b) the incidence function f7(Y ), showing two intersection points with
an inset.
only one equilibrium solution would exist if we only consider the second equation in (9), as
shown Figure 2 (a). However, when considering both conditions given in (9) for equilibrium
solutions, we will have two intersection points between f7 and g2. According to the first
equation in (9), that is f5(X , Y ) = 0, we can use Y to express X in the equilibrium state as
X¯(Y ) = (Y +C)[(A+B)Y 2+(BC+D)Y +DC]−1. Substituting X¯(Y ) into f7(X , Y ) in (11), we
obtain
f7(Y ) = Y [(A+B)Y +BC][(A+B)Y 2+(BC+D)Y +CD]−1, (12)
and ∂∂Y f7(Y ) = D[(A+B)Y
2 + 2(A+B)CY +BC2][(A+B)Y 2 +(BC+D)Y +CD]−2 > 0 for
all X , Y > 0. However, the sign of ∂
2
∂Y 2 f7(Y ) = −2D[(A+B)2Y 3 + 3C(A+B)2Y 2 + 3(A+
B)BC2Y +(B2C−AD)C2][(A+B)Y 2+(BC+D)Y +CD]−3, could alter at the inflection point
from positive to negative as Y increases. Therefore, with appropriate parameter values, f7(Y )
can have a convex-concave ‘S’ shape, yielding two intersection points with the ray line, g2(y),
in the first quadrant of the X-Y plane, as shown in Figure 2 (b). The above discussion, as
illustrated in Figure 2, implies that system (4) can have two positive equilibrium solutions
when R0 < 1, and thus backward bifurcation may occur.
Remark 1 Summarizing the discussions and results given in this section indicates that a dis-
ease model with a convex-concave incidence function may lead to backward bifurcation, which
in turn implies: (a) the system has at least two equilibrium solutions, and the two equilibrium
solutions intersect at a transcritical bifurcation point; and (b) at least one of the equilibrium
solutions is determined by a nonlinear equation.
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5 Hopf bifurcation
In the previous section, we studied backward bifurcation and established the necessary con-
ditions for the occurrence of backward bifurcation in two models. In this section, we turn to
Hopf bifurcation, since it typically underlies the change of stability in the upper branch of the
infected equilibrium, the key condition in determining whether a model can exhibit oscillation
or even recurrence. Again, we will present detailed studies for the two models.
5.1 Hopf bifurcation in the infection model with concave incidence
In this subsection, we study two cases of an infection model with concave incidence: sys-
tem (6) and (7). First, we discuss the equilibrium solutions and their stability by using the
Jacobian matrix, denoted by J, and examining the corresponding characteristic polynomial,
P|J(L) = L2+Tr(J)L+Det(J). (13)
Bifurcation analysis is conducted by choosing Λ as the bifurcation parameter.
First, we consider the case without saturating medical treatment, system (6). This system
satisfies the three conditions in (3), and consequently, its uninfected equilibrium E¯0 = (Λd , 0)
is globally asymptotically stable if R0 =
βΛ
(d+γ+ε)d ≤ 1, while the infected equilibrium E¯1 =
(kΛ+d+γ+εdk+β ,
βΛ−(d+γ+ε)d
(dk+β )(d+γ+ε)) emerges and is globally asymptotically stable if R0 > 1. Therefore,
for this case the system has only one transcritical bifurcation point at R0 = 1 and no complex
dynamics can occur.
Next, with the saturating treatment term, system (7) violates the conditions established for
model (3), but leads to the possibility of complex dynamical behaviors. In fact, evaluating the
Jacobian matrix J1 = J|(7)(E¯0) at the uninfected equilibrium, E¯0 = (Λd , 0), yields the character-
istic polynomial in the form of (13), denoted by P|J1(L), with Tr(J1) =
(
−βΛd + ε +αω +2d
)
,
and Det(J1) =
(−βΛ+d2+dε+ αdω )= Tr(J1)d−d2. This indicates that
Det(J1) < 0 when Tr(J1) = 0, and thus Hopf bifurcation cannot occur from E¯0. On the other
hand, a static bifurcation can occur when Det(J1) = 0, that is, ΛS = 1β (d
2+dε+ αdω ), where the
subscript ‘S’ refers to static bifurcation. Therefore, E¯0 is stable (unstable) for Λ< ΛS (> ΛS),
or R0 < 1(> 1), with R0 = βΛd−1(d+ γ+ ε+ αω )
−1 [49].
We will show that complex dynamical behaviors can emerge in system (7) from the in-
fected equilibrium E¯1 = (S¯, I¯), where I¯ is determined from the equation F (I) = 0 in (8). In
the Λ-I plane, the bifurcation diagram as shown in Figure 3 (1)-(4), indicates a turning point
on the curve with appropriate parameter values, determined by both the quadratic equation (8)
and the relation dΛdI = −∂F∂ I /∂F∂Λ = 0, which is equivalent to ∂F∂ I = 0. Solving ∂F∂ I = 0 yields
the turning point of I, denoted by IT (‘T ’ means turning), taking the form
IT =
1
2
[
βΛT
(dk+β )(d+ ε)
−ω− d
dk+β
− α
d+ ε
]
,
where ΛT is obtained fromF (IT ) = 0, see (8). Thus, when IT > 0 (< 0), the turning point of
the quadratic curve appears above (below) the I-axis, meaning that backward bifurcation oc-
curs for I > 0 (< 0). Evaluating the Jacobian matrix at the infected equilibrium E¯1, and further
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denoting it as J2 = J|(7)(E¯1), we obtain the characteristic polynomial in the form of (13), with
Tr(J2) = a11/[(ω+ I)2(kI+1)(dkI+β I+d)] and Det(J2) = a21/[(ω+ I)2(kI+1)(dkI+β I+
d)], where a11 = a1a−a1b and a21 = a2a−a2b, with a1b = βΛ(ω+ I)2 and a2b = da1b, and a1a
and a2a only contain positive terms (their expressions are omitted here for brevity). Therefore,
we can rewrite Det(J2) = a21d d/[(ω+ I)
2(kI+1)(dkI+β I+d)]. Determining whether a Hopf
bifurcation can occur from E¯ is equivalent to finding whether Det(J2) remains positive when
Tr(J2) = 0. Ignoring the positive factors in the following subtraction yields
h1(I) =
Tr(J2)−Det(J2)/d
(ω+ I)2(kI+1)(dkI+β I+d)
= a11− 1d a21 = a1a−
1
d
a2a,
where h1(I) = 1d (dkI+β I+d)[(kI+1)d
2(ω+ I)2−βεI(ω+ I)2−αβωI]. Thus, when a1a =
0, 1d a2a and h1(I) have opposite signs, implying that when Tr(J2)= 0, Det(J2) could be positive
only if h1(I) is negative. Therefore, the necessary condition for system (7) to have a Hopf
bifurcation from the infected equilibrium E¯1 is that h1(I) is negative.
In the remaining part of this subsection, we demonstrate various dynamics which may
happen in system (7) with different parameter values of k, as shown in Table 1. Taking other
parameter values as α = 6, ω = 7, ε = 0.02, γ = 0.01, β = 0.01, and d = 0.1, and solving
the two equations Tr(J2) = 0 andF (I) = 0 in (8) gives the Hopf bifurcation point candidates,
(ΛH , IH), for which h1(IH) < 0. Since the formula for the transcritical bifurcation point ΛS
has no relation with k, (ΛS, IS) = (9.87, 0) is a fixed value pair in Table 1. Bifurcation dia-
grams and associated numerical simulations are shown in Figure 3 corresponding to the five
cases given in Table 1. The blue lines and red curves represent the uninfected equilibrium E¯0
and infected equilibrium E¯1, respectively. The stable and unstable equilibrium solutions are
shown by solid and dashed lines/curves, respectively. Backward bifurcation occurs in Cases
1, 2, and 3 (see Table 1), which are illustrated by the corresponding bifurcation diagrams in
Figures 3(1), (2), and (3), respectively. For Cases 1 and 2, only one Hopf bifurcation occurs on
the upper branch of the infected equilibrium E¯1, and this bifurcation point exists at the critical
point ΛH < ΛS for Case 1 and ΛH > ΛS, for Case 2. For Case 1 with Λ= 9.78, the simulated
time history converges to E¯0 with initial condition IC= [93.6, 0.44], shown in Figure 3(1a),
but converges to E¯1 with initial condition IC= [46.8, 10], shown in Figure 3(1b). This clearly
indicates the bistable behavior when ΛH < ΛS, and an overlapping stable region for both E¯0
and E¯1 exists (see Figure 3(1)). The recurrent behavior for Case 2 is simulated at Λ = 9.87
with IC= [50, 5], shown in Figure 3(2a). For Case 2, ΛH > ΛS, and an overlapping unstable
parameter region for both E¯0 and E¯1 occurs between ΛS and ΛH (see Figure 3(2)). For Case 3,
two Hopf bifurcations occur on the left side of ΛS, and a stable part in the upper branch of E¯1
exists when Λ passes through the critical value Λ= ΛS. In this case, although backward bifur-
cation still exists and the turning point is also located above the Λ-axis, giving two branches
of biologically feasible E¯1, only regular oscillating behavior is observed. The simulated time
history is conducted at Λ= 10, with initial condition IC= [50, 2], shown in Figure 3(3a). For
Case 4, only forward bifurcation occurs in the biologically feasible region, and the turning
point for backward bifurcation moves down to the fourth quadrant, that is, negative backward
bifurcation occurs in this case. The whole upper branch of E¯1 in the first quadrant is stable,
therefore, no oscillations (or recurrence) can happen. Finally, further increases to the value of
k change the shape of the red curves, as shown in Figure 3(5), which again indicates that no bi-
ologically meaningful backward bifurcation or oscillations can occur. Note that in Figure 3(5)
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Table 1: Dynamics of system (7) for different values of k, with α = 6, ω = 7, ε = 0.02,
γ = 0.01, β = 0.01, d = 0.1, and a fixed transcritical bifurcation point (ΛS, IS) = (9.87, 0).
Case k (ΛT , IT ) h1(I)< 0 (ΛH , IH) Dynamics Notes
1 0.001 (9.48, 4.57) I ∈ [1.72, ∞] (9.73, 10.28) Bistability ΛH < ΛS
2 0.01 (9.71, 2.82) I ∈ [1.76, ∞] (9.96, 8.00) Recurrence ΛH > ΛS
3 0.02 (9.85, 0.84) I ∈ [1.82, ∞] (9.88, 2.09),
(10.14, 5.62)
Oscillation Two Hopf
critical points
4 0.027 (9.86,−0.65) I ∈ [1.85,30.65] No Hopf No
oscillation
Negative
backward
bifurcation
5 0.05 No Turning I ∈ [2.01,15.03] (6.18,−22.15) No
oscillation
No backward
bifurcation
a Hopf bifurcation point exists on the lower branch of the equilibrium solution, which is bi-
ologically unfeasible since it is entirely below the horizontal axis. In conclusion, interesting
dynamical behaviors can emerge in system (7) if backward bifurcation occurs.
5.2 Hopf bifurcation in the infection model with convex incidence
In this subsection, we return to system (4), that is, the 2-dimensional HIV model with convex
incidence derived in [47, 48], and analyze the various dynamical phenomena which system (4)
could possibly exhibit. To achieve this, we set B as the bifurcation parameter, and A as a control
parameter; the bifurcation analysis will be carried out for various values of A. Also, simulated
time histories are provided to illustrate the dynamical behavior predicted in the analysis.
We first consider the uninfected equilibrium E¯0 = ( 1D , 0), which has two eigenvalues. One
of them, given by λ1|E¯0 = −D, is always negative. The other one is λ2|E¯0 = BD − 1. Thus,
depending upon the relation between B and D, λ2|E¯0 = 0 gives a static bifurcation at BS = D
(or R0 = BD = 1), which is further proved to be a transcritical bifurcation. Here the ‘S’ in
subscript stands for static bifurcation. Therefore, E¯0 is stable when B < D (or R0 < 1), loses
its stability and becomes unstable when B increases to pass through BS = D, that is B > D (or
R0 > 1), and no other bifurcations can happen.
Next, we examine the infected equilibrium E¯1 = (X¯ , Y¯ ). Since X¯(Y ) = Y+C(A+B)Y+BC , Y¯ is
determined by the quadratic equation (10), which gives the turning point (BT , YT ) as
BT =
−A+D+2√ACD
C+1
, YT =
A+B−BC−D
A+B
,
where ‘T ’ in the subscript stands for turning bifurcation. We perform a further bifurcation
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Figure 3: Bifurcation diagrams and simulations associated with the five cases given in Table 1,
demonstrating various dynamical behaviors.
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analysis on its corresponding characteristic polynomial (13), which takes the form
P|E¯1(λ ,Y ) = λ 2+
a1a
[(A+B)Y +BC](Y +C)
λ +
a2a
[(A+B)Y +BC](Y +C)
, where
a1a = (A+B)2Y 3+(2BC+D)(A+B)Y 2+(B2C2+ACD+2BCD−AC)Y +BC2D,
a2a = (A+B)2Y 3+2(A+B)BCY 2+(B2C−AD)CY.
(14)
Therefore, the sign of the subtraction between the trace and determinant is determined by
h2(Y ) = a1a−a2a = D(A+B)Y 2+[2CD(A+B)−AC]Y +BC2D. Here the equilibrium solu-
tion of Y and other parameters satisfy the quadratic equation (10), which leads to an explicit
expression, given by B¯ =−AY 2+(D−A)Y+CDY 2+(C−1)Y−C . Substituting B = B¯ into h2(Y ), we obtain
h2(Y )|B=B¯ = a1a−a2a =
[AC(D−1)−D2]Y 2− [AC(D−1)+2CD2]Y −C2D2
Y −1 .
Hopf bifurcation may occur when the trace is zero, while the determinant is still positive. This
implies h2(Y ) < 0, which is possible with appropriately chosen parameter values. Hence, by
solving a1a = 0 in (14) together with the quadratic equation (10), we get two pairs of points
denoted by (Bh1, Yh1) and (Bh2, Yh2), which are candidates for Hopf bifurcation. Then vali-
dating the above two points by substituting them back into the characteristic polynomial (14),
respectively, we denote the Hopf bifurcation point as (BH , YH) if this validation confirms their
existence. According to (Yu et al., submitted for publication), Hopf bifurcation can happen
only from the upper branch of the infected equilibrium E¯1.
The various dynamical behaviors which may appear in system (4) have been classified in
Table 2 for different values of the parameter A, with fixed values of C = 0.823 and D = 0.057.
Thus, the transcritical bifurcation point is fixed for all cases: BS = D = 0.057 and YS = 0. The
two solutions Bh1 and Bh2 are solved from the two equations (14) P|E¯1(λ ,Y ) = 0 and (10)
F5(Y ) = 0, respectively. They become a Hopf bifurcation point only if their corresponding Y
values (Yh1 and Yh2, respectively) are in the range such that h2(Y )< 0. Otherwise, system (4)
has a pair of real eigenvalues with opposite signs at (Bh1, Yh1) or (Bh2, Yh2), which is denoted
by the superscript ‘∗’ (which is actually a saddle point) in Table 2, while the Hopf bifurcation
point is denoted by the superscript ‘H’ in Table 2.
Next, we further examine the direction of the Hopf bifurcation, that is, check whether it is a
supercritical or subcritical Hopf bifurcation. Since the Jacobian matrix of the system evaluated
at the Hopf bifurcation point has a pair of purely imaginary eigenvalues, the linearized system
(4) does not determine the nonlinear behavior of the system. Therefore, we take advantage
of normal form theory to study the existence of the limit cycles bifurcating from the Hopf
bifurcation point as well as their stability. As mentioned earlier, Hopf bifurcation can only
occur from the upper branch of the infected equilibrium E¯1, therefore we first transform the
fixed point E¯1 to the origin by a shifting transformation, and, in addition, make the parameter
transformation B=BH+µ; the Hopf bifurcation point is thus defined as µ = µH = 0. Then the
normal form of system (4) near the critical point, µ = µH = 0, takes the form up to third-order
approximation:
r˙ = d µ r+ar3+O(r5), θ˙ = ωc+ cµ+br2+O(r4), (15)
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Table 2: Parameter values taken to illustrate various dynamics of system (4). The fixed
transcritical bifurcation point: (BS, YS) = (0.057, 0)
Case A (BT , YT ) h2(Y )< 0, Y ∈ (Bh1, Yh1)
1 0.80 (−0.1950, 0.5850) (0.0036, 0.9830) (0.0355, 0.8725)H
2 0.71 (−0.1580, 0.5660) (0.0040, 0.9800) (0.0539, 0.0038)∗
3 0.60 (−0.1140, 0.5380) (0.0048, 0.9769) (0.0540, 0.0045)∗
4 0.07 (0.0557, 0.0909) (0.0476, 0.8030) (0.0560, 0.0470)∗
5 0.06 (0.056558, 0.05581) (0.0574, 0.7700) (0.056559, 0.0574)H
6 0.05 (0.05697, 0.01442) (0.0724, 0.7232) (0.0574, 0.0741)H
7 0.04 (0.0569,−0.0358) (0.0986, 0.6507) (0.0592, 0.1071)H
8 0.03 (0.0559,−0.0994) (0.1611, 0.5149) —
Case A (Bh2, Yh2) Dynamics Notes
1 0.80 (0.054, 0.0034)∗ Unstable limit cycle,
Bistable
Bh1 < BS
2 0.71 (0.0574, 0.8650)H Recurrence Bh2 > BS
3 0.60 (0.0819, 0.8530)H Recurrence Bh2 > BS
4 0.07 (0.1015, 0.5612)H Recurrence Bh2 > BS
5 0.06 (0.0961, 0.5225)H Recurrence Bh1 < BS < Bh2
6 0.05 (0.0894, 0.4701)H Recurrence Bh1 < BS < Bh2
7 0.04 (0.0806, 0.3897)H Oscillation Bh1 < BS < Bh2,
YT < 0
8 0.03 — E¯1 stable YT < 0
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Table 3: Classification of Hopf bifurcations based on the normal form (15).
Class Stability of r¯ = 0 Stability of r¯2=−dµa Hopf bifurcation
µ < 0 µ > 0 µ < 0 µ > 0
(a): d > 0, a > 0 stable unstable unstable – subcritical
(b): d > 0, a < 0 stable unstable – stable supercritical
(c): d < 0, a > 0 unstable stable – unstable subcritical
(d): d < 0, a < 0 unstable stable stable – supercritical
Table 4: Classification of Hopf bifurcations appearing in Table 2.
Case A Hopf bifurcation
point (BH , YH)
d a Stability of
limit cycles
Table 3
class
1 0.8 (0.0355, 0.8725) −1.0722 0.2114×10−2 Unstable (c)
2 0.71 (0.0574, 0.8650) −1.0726 0.1424×10−2 Unstable (c)
3 0.6 (0.0819, 0.8530) −1.0733 0.6755×10−3 Unstable (c)
4 0.07 (0.1015, 0.5612) −1.0307 −0.8791×10−3 stable (d)
5 0.06 (0.056559, 0.0574) 884.27 −0.1019 Stable (b)
(0.0961, 0.5225) −1.0079 −0.8613×10−3 Stable (d)
6 0.05 (0.0574, 0.0741) 18.232 −0.3145×10−2 Stable (b)
(0.0894, 0.4701) −0.9629 −0.8457×10−3 Stable (d)
7 0.04 (0.0592, 0.1071) 4.7242 −0.1577×10−2 Stable (b)
(0.0805, 0.3897) −0.8437 −0.8438×10−3 Stable (d)
where r and θ represent the amplitude and phase of the motion, respectively. The first equation
of (15) can be used for bifurcation and stability analysis, while the second equation of (15) can
be used to determine the frequency of the bifurcating periodic motions. The positive ωc in the
second equation of (15) is the imaginary part of the eigenvalues at the Hopf bifurcation point.
The parameters d and c can be easily obtained from a linear analysis, while a and b must be
derived using a nonlinear analysis, with the Maple program available in, say, [46].
Note that the infected equilibrium E¯1 is represented by the fixed point r¯ = 0 of system
(15), while the nonzero fixed point r¯ > 0 (satisfying r¯2 = −dµa ) is an approximate solution for
a limit cycle or periodic orbit. The periodic orbit is asymptotically stable (unstable) if a < 0
(a> 0), and the corresponding Hopf bifurcation is called supercritical (subcritical). According
to the Poincare-Andronov Hopf Bifurcation theorem [44], for µ sufficiently small, there are
four possibilities for the existence of periodic orbits and their stability, which are classified
in Table 3, based on the four sets of the parameter values in the normal form (15). Then we
use the results presented in Table 3 with a nonlinear analysis based on normal form theory to
classify the Hopf bifurcations appearing in Table 2, and the results are shown in Table 4.
To illustrate the analytical results given in Tables 2 and 4, we provide the bifurcation di-
agrams in Figures 4 (1)-(8). These figures depict the uninfected equilibrium E¯0 and the in-
fected equilibrium E¯1 in blue and red, respectively. The solid and dashed lines differentiate
stable and unstable states of the equilibrium solutions. The bifurcation points on the equi-
librium solutions are highlighted by solid black dots. Moreover, ‘Transcritical’, ‘Turning’,
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‘Hopfsub’, and ‘Hopfsuper’, are used to denote Transcritical bifurcation, Turning point, sub-
critical Hopf bifurcation, and supercritical Hopf bifurcation, respectively. Simulated time
histories are used to validate the analytical results, and to show different dynamical behav-
iors in each case listed in Tables 2 and 4. Subcritical Hopf bifurcation occurs in Cases
1-3, shown in Figures 4 (1)-(3). A = 0.8 is used in Figure 4 (1) for Case 1. Choosing
B = 0.036, we have E0 = [17.1282566, 0.023689] and E1 = [2.233533, 0.8726886]. The sim-
ulated solution converges to E0 or E1, with initial condition taken as ICd = [17.13, 0.024]
or ICc = [2.233, 0.873], shown in Figures 4 (1d) and (1c), respectively. Figures 4 (1a) and
(1b), on the other hand, show the unstable limit cycle bifurcating from the subcritical Hopf
bifurcation with ICc = [2.233, 0.873].
Figure 4 (2) corresponds to Case 2 with A = 0.71. Choosing B = 0.0572 ∈ [BS, BH ] yields
recurrence, independent of the initial conditions, see, for example, the result given in Figure 4
(2b) with ICb = [2.4, 0.5]. However, for B = 0.06 > BH , the simulated time history converges
to E1, with an initial condition close to E1, such as ICa = [2.4, 0.6] as shown in Figure 4 (2a);
or shows recurrence with an initial condition far away from E1, such as ICc = [2.4, 0.4], as
shown in Figure 4 (2c).
Figure 4 (3) plots the result for Case 3 with A = 0.6, and shows a broader region between
the transcritical and Hopf bifurcation points, associated with a larger recurrent region. Re-
currence occurs independent of the initial conditions for B = 0.083 ∈ [BS, BH ], giving E0 =
[12.048, 0] and E1 = [2.576, 0.852], as shown in Figures 4 (3a) and (3b), with ICa = [2.7, 0.84]
and ICb = [14, 0.1], respectively. But if we choose B = 0.07 > BH , we have E0 = [14.286,0]
and E1 = [2.67, 0.8478]. The time history converges to E1 with ICc = [2.6, 0.8], or shows
recurrence with ICd = [2.6, 0.1], as shown in Figure 4 (3c) and (3d), respectively.
Supercritical Hopf bifurcations occur in Cases 4-7, as shown in Figures 4 (4)-(7). Fig-
ure 4 (4) depicts the result for Case 4 with A = 0.07. Only one supercritical Hopf bifurcation
happens in this case, and gives a large recurrent parameter region between the transcritical
and Hopf bifurcation points. Although the simulated recurrent behavior does not depend on
initial conditions, the recurrent pattern will fade out with the growth of the value of B from
the transcritical point to the Hopf bifurcation point, see Figures 4 (4a) and (4b) with the same
ICa,b = [8, 0.1], but different values of B: B = 0.06 and B = 0.09, respectively.
Figure 4 (5) shows the result for Case 5 with A = 0.06. A transcritical bifurcation hap-
pens between two supercritical Hopf bifurcations. The recurrent region still starts from the
transcritical point and independent of the initial conditions, but is narrower than that shown in
Figure 4 (4). The simulated recurrent behavior for this case is conducted at IC= [12, 0.1] and
B = 0.06. Figure 4 (6) corresponds to Case 6 with A = 0.05, and two supercritical Hopf bifur-
cations occur on the right side of the transcritical bifurcation point, which makes the recurrent
region even narrower and the recurrent pattern less obvious, as shown in the simulated time
history with IC= [10, 0.1] and B= 0.06. Negative backward bifurcations occur in Cases 7 and
8, as shown in Figure 4 (7) and (8). Although two Hopf bifurcations are still present in Case
7, see Figure 4 (7), only a regular oscillating pattern exists. For Case 8, no Hopf bifurcation
happens in the biologically feasible part of E1, and therefore no more interesting dynamics
occur.
In general, backward bifurcation, which occurs above the horizontal axis, is much more
likely to induce Hopf bifurcation. A Hopf bifurcation can only occur along the upper branch
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of E¯1, since E¯0 only changes its stability at a transcritical bifurcation point, and any point
on the lower branch of E¯1 is a saddle node (Yu et al., submitted for publication). Moreover,
Hopf bifurcation can lead to a change in the stability of the upper branch of the infected
equilibrium E¯1. Thus the system further develops bistable, recurrent, or regular oscillating
behavior, corresponding to Cases 1−7 in Tables 2 and 4, and in Figures 4 (1)-(7). In particular,
bistability happens when both equilibria E¯0 and E¯1 share a stable parameter region, see Case
1 in Table 2 and Figure 4 (1).
As for recurrent behavior, we observe that recurrence is more likely to happen if the fol-
lowing two conditions are satisfied for the upper branch of E¯1: (1) the equilibrium remains
unstable as the bifurcation parameter increases and crosses the trancritical point, where E¯0 and
E¯1 intersect, such that the two equilibria share an unstable parameter range; and (2) at least one
Hopf bifurcation occurs from E¯1. As shown in Cases 2-6 in Table 2, and the corresponding
Figures 4 (2)-(5), the common recurrent parameter region for both subcritical and supercritical
Hopf bifurcations starts beside the transcritical point, and is located entirely in the unstable
parameter region of E¯0 and E¯1. The simulated recurrent pattern becomes more pronounced
if the value of the bifurcation parameter is close to the transcritical point, but approaches an
oscillatory pattern as the parameter diverges from the transcritical point, as shown in Figure 4
(4a) and (4b). In this common recurrent parameter region, recurrence occurs independent of
initial conditions; see Figures 4 (3a) and (3b). In addition to the common recurrent region,
for subcritical bifurcation, seen in Table 2 for Cases (2) and (3) and Figures 4 (2) and (3),
recurrence may also appear on the stable side of the subcritical Hopf bifurcation point with an
initial condition close to E¯1. Moreover, the subcritical Hopf bifurcation and the transcritical
point should be close to each other for a clear recurrent pattern. When this is not the case,
the periodic solutions show a more regular oscillating pattern, as compared in Figures 4 (2c)
and (3d). Although two Hopf bifurcation points occur in Table 2 for Case 5, see Figure 4 (5),
the transcritical point is located inside the unstable range of the upper branch of E¯1, between
the two Hopf bifurcation points. A recurrent pattern still characterizes the dynamical behavior
in this case. However, if the unstable range of E¯1, between the two Hopf bifurcation points,
is located entirely in the unstable range of E¯0, and moves further away from the transcritical
point, the recurrent motion gradually becomes a regular oscillation, as shown in Figures 4 (6)
and (7).
Summarizing the results and discussions presented in the previous two sections, we have
the following observations.
1. Due to the fact that E¯0 only changes its stability at the transcritical bifurcation point, and
the fact that any point on the lower branch of E¯1 is a saddle node, Hopf bifurcation can
only occur from the upper branch of E¯1. A Hopf bifurcation may result in convergent,
recurrent, bistable, or regular oscillating behaviors.
2. Backward bifurcation gives rise to two branches in the infected equilibrium E¯1. Hopf
bifurcation is more likely to happen when the turning point of the backward bifurcation
is located on the positive part of the equilibrium solution in the bifurcation diagram, as
shown in Figures 4 (2)-(6). This means that we have two biologically feasible infected
equilibria, which is essential to observe bistability, as shown in Figure 4 (1).
3. However, if the turning point on the infected equilibrium E¯1, or the backward bifurcation
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moves down to the negative part of a state variable in the bifurcation diagram, that is,
negative backward bifurcation occurs, then Hopf bifurcation is very unlikely to happen.
Although Figure 4 (7) shows an exceptional case, the parameter range for such a Hopf
bifurcation is very narrow.
4. The bifurcation diagram for system (4) with A= 0.03, shown in Figure 4 (8), is a typical
model with negative backward bifurcation. Such negative backward bifurcation may
occur in higher-dimensional systems. However, by considering more state variables,
which make the system more complicated, Hopf bifurcation can happen in the upper
branch of the negative backward bifurcation. We will discuss this possibility in more
detail in the next section by examining an autoimmune disease model.
The results obtained in this section suggest the following summary.
Remark 2 If a disease model contains a backward bifurcation on an equilibrium solution,
then as the system parameters are varied, there may exist none, one or two Hopf bifurcations
from the equilibrium solution, which may be supercritical or subcritical. If further this equi-
librium has a transcritical bifurcation point at which it exchanges its stability with another
equilibrium, then recurrence can occur between the transcritical and Hopf bifurcation points
and near the transcritical point, where both equilibrium solutions are unstable, and bistability
happens when Hopf bifurcation makes a shared stable parameter region for both equilibria.
6 Negative backward bifurcation in an autoimmune disease
model
In the previous section, we examined three cases of negative backward bifurcation: Table 1
Case 4 for system (7) and Table 2 Case (7) and (8) for system (4). The analytical and numerical
results showed that solutions typically converge to the infected equilibrium in these cases,
and the parameter range for Hopf bifurcation is very limited. As a result, negative backward
bifurcation tends to give no interesting behavior. In this section, however, we shall explore
an established autoimmune model [1] in which negative backward bifurcation occurs. We
demonstrate that after modification, the autoimmune model can also exhibit recurrence.
The autoimmune model [1] takes the form
dA
dt
= f v˜G− (σ1Rn+b1)A−µAA
dRn
dt
= (pi1E +β )A−µnRn
dE
dt
= λEA−µEE
dG
dt
= γE− v˜G−µGG,
(16)
where mature pAPCs (A) undergo maturation by intaking self-antigen (G), at rate f v˜, and are
suppressed by specific regulatory T cells, TReg cells (Rn), at rate σ1; b1 represents additional
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non-specific background suppression. The TReg cells are activated by mature pAPCs at a rate
proportional to the number of auto-reactive effector T cells (E) at rate pi1, and by other sources
at rate β . Active auto-reactive effector T cells (E) come from the activation process initiated
by mature pAPCs, at rate λE , then attack healthy body tissue and release free self-antigen (G)
at rate γ , which is ready for mature pAPCs to engulf; the antigen engulfing rate is v˜. The death
rates of the populations A, Rn, E, and G are denoted by µA, µn, µE , and µG, respectively.
Following the steps described by Zhang et al. (submitted for publication), system (16), can
be reduced via quasi-steady state analysis to a 2-dimensional system:
dA
dt
= [
f v˜γλE
µE(v˜+µG)
−b1−µA]A−σ1RnA,
dRn
dt
= (
pi1λE
µE
A+β )A−µnRn.
(17)
For simplicity, we set a = f v˜γλEµE(v˜+µG) − b1− µA and b =
pi1λE
µE . For the stability and bifurcation
analysis, we choose λE as the bifurcation parameter. System (17) has a disease-free equilib-
rium E¯0 =(0, 0), which is stable if a> 0 or λE >
(b1+µA)(v˜+µG)µE
f v˜γ ; and unstable if a< 0 or λE <
(b1+µA)(v˜+µG)µE
f v˜γ . Thus a static bifurcation occurs on E¯0 when a = 0 or λE =
(b1+µA)(v˜+µG)µE
f v˜γ .
The disease equilibrium is given by E¯1 = (A¯, R¯n), in which R¯n =
(bA¯+β )A¯
µn , and A¯ is given by
the roots of the following equation,
f8(A) = bσ1A2+βσ1A−µna. (18)
Equation (18) has two roots with negative signs if a < 0, with opposite signs if a > 0, and
only one zero root if a = 0. This means that a negative backward bifurcation is possible in
system (17) with proper parameter values. We further examine the characteristic equation
at E¯1, which shares the same form as equation (13), with Tr(J|E¯1) = 1µn (bσ1A2 + βσ1A+
µ2n − aµn) := a11 and Det(J|E¯1) = 3bσ1A2 + 2βσ1A− aµn := a12. Solving f8(A) = 0 and
a12 = Det(J|E¯1) = 0, gives the static bifurcation point of E¯1 at (A¯, a) = (0, 0) or (A¯, λE) =
(0, (b1+µA)(v˜+µG)µEf v˜γ ), which is a transcritical bifurcation point between E¯0 and E¯1. Moreover,
Hopf bifurcation can happen if and only if f8(A) = 0 and a11 = Tr(J|E¯) = 0, which can be
satisfied only if µn = 0. This implies that the positive branch of E¯1 is stable for any positive
values of µn. Thus, this model cannot exhibit recurrence, bistability, or even regular oscillation.
The same conclusion was obtained in Zhang et al., (submitted for publication) for the original
4-dimensional model (16).
However, a recent experimental discovery [3] has revealed a new class of terminally dif-
ferentiated TReg cells. As described in detail in Zhang et al., (submitted for publication),
introducing this cell population, denoted Rd , into the model yields the full system
dA
dt = f v˜G−σ1(Rn+dRd)A− (b1+µA)A
dRn
dt = (pi1E +β )A−µnRn−ξRn
dRd
dt = cξRn−µdRd
dE
dt = λEA−µEE
dG
dt = γE− v˜G−µGG
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and quasi-steady state analysis then yields a reduced 3-dimensional model in the form
dA
dt = [
f v˜γλE
(v˜+µG)µE
− (b1+µA)]A−σ1(Rn+dRd)A,
dRn
dt = (
pi1λE
µE A+β )A−µnRn−ξRn,
dRd
dt = cξRn−µdRd.
Again, here λE is chosen as the bifurcation parameter for stability and bifurcation analysis. It is
easy to show that system (6) still has a disease-free equilibrium E¯0 as (A, Rn, Rd) = (0, 0, 0),
and a disease equilibrium E¯1 as (A¯, R¯n, R¯d), where R¯d =
cξ R¯n
µd , R¯n =
βµE+pi1λE A¯
µE(µn+ξ )
A¯, and A¯ is
determined from the following quadratic equation:
f9(A) = pi1λEA2+βµEA+
µd(µn+ξ )
(v˜+µG)(cdξ +µd)σ1
[− f γ v˜λE +(b1+µA)(µG+ v˜)µE ],
which gives two negative roots if λE < λES =
(b1+µA)(µG+v˜)µE
f γ v˜ , and two roots with opposite
signs when λE > λES. The critical point is determined by λE = λES, which is actually the
intersection point of E¯0 and E¯1. The two equilibrium solutions exchange their stability at λES,
leading to a transcritical bifurcation at (A¯, λE) = (0, λES). Note that the negative backward
bifurcation still happens in system 6. Moreover, a Hopf bifurcation occurs from the upper
branch of E¯1, giving rise to oscillation and recurrence.
Realistic parameter values have been obtained in Zhang et al., (submitted for publication),
and are given as follows:
f = 1×10−4, v˜ = 0.25×10−2, σ1 = 3×10−6, b1 = 0.25, µA = 0.2, pi1 = 0.016,
β = 200, µn = 0.1, µE = 0.2, γ = 2000, µG = 5, µd = 0.2, c = 8, d = 2, ξ = 0.025.
For the above parameter values, the Hopf critical point is obtained at (AH , λEH)= (5.6739,
1691.6414), while the turning point is at (AT , λET ) = (−1.4205, 879.9848), and the trans-
critical bifurcation point is at (AS, λES)=(0, 900.45). These three bifurcation points and the
stability of equilibrium solutions are shown in the bifurcation diagram given in Figure 5(a),
and the simulated recurrent time history is plotted in Figure 5(b) for λE = λEH +1000.
In summary, when negative backward bifurcation occurs, that is, the turning point is lo-
cated in the negative state variable space, less complex dynamical behavior will be present.
Hopf bifurcation in a biologically feasible area does not happen in the reduced 2-dimensional
system (17), nor in the original system (16) (Zhang et al., submitted for publication). How-
ever, if we increase the dimension of the system, Hopf bifurcation and complex dynamical
phenomena can emerge, as shown in our results for system (6).
7 Conclusion
In this paper, we first review previous work on a reduced 2-dimensional infection model with
a concave incidence rate [28]. The authors proved that the disease equilibrium will emerge
and be globally stable when the basic reproduction number R0 is greater than 1. This means
that no complex dynamical phenomenon can occur in such models. However, by adding an
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Figure 5: Dynamics of system (17): (a) bifurcation diagram; and (b) simulated time history
for λE = λEH +1000.
extra saturating treatment term to this simple 2-dimensional infection model, the resulting
system (6) considered in [49] can exhibit backward bifurcation, which increases the parameter
range for Hopf bifurcation, which in turn leads to recurrent, bistable and regular oscillating
behaviors.
Instead of adding an extra term, a 2-dimensional infection model with a convex incidence
function can likewise show rich dynamics due to the occurrence of backward bifurcation, giv-
ing rise to two types of Hopf bifurcation. Biologically, a convex incidence rate implies that
existing infection makes the host more vulnerable to further infection, showing a cooperative
effect in disease progression. From the view point of mathematics, the convex incidence func-
tion enables backward bifurcation to occur on the positive branch of the disease equilibrium
solution, which further generates Hopf bifurcation. The location and direction of Hopf bi-
furcation(s), determined by parameter values, can further give rise to bistable, recurrent, and
regular oscillating behaviors.
Cooperative effects also occur during the progression of autoimmune disease. However,
for an autoimmune model with negative backward bifurcation, in which the turning point
is located on the negative state variable space, the biologically feasible parameter range in
which Hopf bifurcation may occur is limited. By introducing an additional state variable to
the autoimmune model, recurrent phenomenon are once again observed.
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